Healthcare provider profile · identity verified

Durga Komaragiri, M.D.

Internal Medicine · FAIRMONT, MN · NPI 1730163460

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Rosuvastatin Calcium	Rosuvastatin Calcium	416	122
Atorvastatin Calcium	Atorvastatin Calcium	409	115
Losartan Potassium	Losartan Potassium	391	112
Levothyroxine Sodium	Levothyroxine Sodium	383	99
Amlodipine Besylate	Amlodipine Besylate	359	99
Furosemide	Furosemide	316	85
Omeprazole	Omeprazole	309	84
Metoprolol Tartrate	Metoprolol Tartrate	281	69
Gabapentin	Gabapentin	256	71
Lisinopril	Lisinopril	231	67
Pantoprazole Sodium	Pantoprazole Sodium	209	58
Metoprolol Succinate	Metoprolol Succinate	187	63
Eliquis	Apixaban	179	43
Simvastatin	Simvastatin	174	50
Metformin Hcl	Metformin Hcl	171	51
Warfarin Sodium	Warfarin Sodium	171	37
Potassium Chloride	Potassium Chloride	169	42
Allopurinol	Allopurinol	166	45
Carvedilol	Carvedilol	156	44
Glimepiride	Glimepiride	145	40
Pravastatin Sodium	Pravastatin Sodium	140	34
Celecoxib	Celecoxib	129	35
Famotidine	Famotidine	128	31
Tamsulosin Hcl	Tamsulosin Hcl	121	37
Torsemide	Torsemide	109	33
Prednisone	Prednisone	106	41
Sertraline Hcl	Sertraline Hcl	101	28
Tramadol Hcl	Tramadol Hcl	101	29
Albuterol Sulfate Hfa	Albuterol Sulfate	100	32
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	97	18
Fluticasone Propionate	Fluticasone Propionate	97	25
Cefdinir	Cefdinir	93	75
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	90	32
Hydrochlorothiazide	Hydrochlorothiazide	85	26
Lorazepam	Lorazepam	85	23
Clopidogrel	Clopidogrel Bisulfate	82	24
Duloxetine Hcl	Duloxetine Hcl	82	14
Isosorbide Mononitrate Er	Isosorbide Mononitrate	82	23
Trazodone Hcl	Trazodone Hcl	82	25
Mirtazapine	Mirtazapine	81	23
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	75	20
Buspirone Hcl	Buspirone Hcl	73	29
Ezetimibe	Ezetimibe	71	18
Citalopram Hbr	Citalopram Hydrobromide	68	17
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	68	20
Metformin Hcl Er	Metformin Hcl	62	17
Ozempic	Semaglutide	60	11
Alprazolam	Alprazolam	59	16
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	59	12
Jardiance	Empagliflozin	56	19
Atenolol	Atenolol	55	16
Finasteride	Finasteride	54	14
Escitalopram Oxalate	Escitalopram Oxalate	53	16
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	53	12
Ventolin Hfa	Albuterol Sulfate	53	24
Alendronate Sodium	Alendronate Sodium	52	15
Pregabalin	Pregabalin	52	11
Baclofen	Baclofen	50	19
Fluoxetine Hcl	Fluoxetine Hcl	50	12
Spironolactone	Spironolactone	47	17
Creon	Lipase/Protease/Amylase	45	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	43	18
Donepezil Hcl	Donepezil Hcl	42	suppressed
Fentanyl	Fentanyl	41	suppressed
Montelukast Sodium	Montelukast Sodium	41	13
Tresiba Flextouch U-200	Insulin Degludec	39	11
Ropinirole Hcl	Ropinirole Hcl	38	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	37	suppressed
Clonazepam	Clonazepam	37	suppressed
Midodrine Hcl	Midodrine Hcl	37	suppressed
Levofloxacin	Levofloxacin	36	21
Venlafaxine Hcl Er	Venlafaxine Hcl	36	13
Xarelto	Rivaroxaban	36	11
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	35	11
Methocarbamol	Methocarbamol	35	suppressed
Myrbetriq	Mirabegron	34	suppressed
Nitroglycerin	Nitroglycerin	33	21
Oxybutynin Chloride	Oxybutynin Chloride	32	suppressed
Azithromycin	Azithromycin	31	14
Cilostazol	Cilostazol	31	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	29	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	29	suppressed
Chlorthalidone	Chlorthalidone	28	suppressed
Hydralazine Hcl	Hydralazine Hcl	28	suppressed
Dulera	Mometasone/Formoterol	27	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	27	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	27	suppressed
Breo Ellipta	Fluticasone/Vilanterol	26	suppressed
Mometasone Furoate	Mometasone Furoate	26	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	25	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	25	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	25	suppressed
Meclizine Hcl	Meclizine Hcl	25	16
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	24	suppressed
Digoxin	Digoxin	24	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	24	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	24	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	23	12
Oxycodone Hcl	Oxycodone Hcl	23	13
Acyclovir	Acyclovir	22	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	22	suppressed
Humalog Kwikpen U-100	Insulin Lispro	22	suppressed
Clonidine Hcl	Clonidine Hcl	21	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	21	suppressed
Lovastatin	Lovastatin	21	suppressed
Amiodarone Hcl	Amiodarone Hcl	20	suppressed
Cefuroxime	Cefuroxime Axetil	20	15
Loperamide	Loperamide Hcl	20	14
Topiramate	Topiramate	20	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	20	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	19	17
Fenofibrate	Fenofibrate	19	suppressed
Minoxidil	Minoxidil	19	suppressed
Mounjaro	Tirzepatide	19	suppressed
Bupropion Hcl Sr	Bupropion Hcl	18	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	18	suppressed
Diazepam	Diazepam	18	suppressed
Farxiga	Dapagliflozin Propanediol	18	suppressed
Hydrocortisone	Hydrocortisone	18	suppressed
Amoxicillin	Amoxicillin	17	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	17	16
Doxycycline Monohydrate	Doxycycline Monohydrate	17	13
Janumet	Sitagliptin Phos/Metformin Hcl	17	suppressed
Levetiracetam	Levetiracetam	17	suppressed
Tizanidine Hcl	Tizanidine Hcl	17	suppressed
Victoza 3-Pak	Liraglutide	17	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	16	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	16	suppressed
Valacyclovir	Valacyclovir Hcl	16	suppressed
Valsartan	Valsartan	16	suppressed
Colchicine	Colchicine	15	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	15	suppressed
Rytary	Carbidopa/Levodopa	15	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	15	suppressed
Bumetanide	Bumetanide	14	suppressed
Humira Pen	Adalimumab	14	suppressed
Nabumetone	Nabumetone	14	suppressed
Novolog Flexpen	Insulin Aspart	14	suppressed
Nystatin	Nystatin	14	suppressed
Sucralfate	Sucralfate	14	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	13	suppressed
Januvia	Sitagliptin Phosphate	13	suppressed
Lithium Carbonate Er	Lithium Carbonate	13	suppressed
Methylprednisolone	Methylprednisolone	13	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	13	suppressed
Terbinafine Hcl	Terbinafine Hcl	13	suppressed
Ulticare Pen Needle	Pen Needle, Diabetic	13	suppressed
Victoza 2-Pak	Liraglutide	13	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	12	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	12	suppressed
Gavilyte-G	Peg3350/Sod Sulf,bicarb,cl/Kcl	12	12
Insulin Aspart Flexpen	Insulin Aspart	12	suppressed
Prazosin Hcl	Prazosin Hcl	12	suppressed
Propranolol Hcl Er	Propranolol Hcl	12	suppressed
Varenicline Tartrate	Varenicline Tartrate	12	suppressed
Belsomra	Suvorexant	11	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	11	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	11	suppressed
Dutasteride	Dutasteride	11	suppressed
Glipizide	Glipizide	11	suppressed
Indapamide	Indapamide	11	suppressed
Isosorbide Mononitrate	Isosorbide Mononitrate	11	suppressed
Modafinil	Modafinil	11	suppressed
Mycophenolate Mofetil	Mycophenolate Mofetil	11	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	11	suppressed
Oxcarbazepine	Oxcarbazepine	11	suppressed
Temazepam	Temazepam	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error